Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CRISPR technology: A versatile tool to model, screen, and reverse drug resistance in cancer
Shiva Shirani-Bidabadi, Aliye Tabatabaee, Nazita Tavazohi, et al.
European Journal of Cell Biology (2023) Vol. 102, Iss. 2, pp. 151299-151299
Open Access | Times Cited: 9

Showing 9 citing articles:

Let’s make it personal: CRISPR tools in manipulating cell death pathways for cancer treatment
Mobina Bayat, Javid Sadri Nahand
Cell Biology and Toxicology (2024) Vol. 40, Iss. 1
Open Access | Times Cited: 9
Preclinical Anticipation of On- and Off-Target Resistance Mechanisms to Anti-Cancer Drugs: A Systematic Review
Paulina J. Dziubańska-Kusibab, Ekaterina Nevedomskaya, Bernard Haendler
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 705-705
Open Access | Times Cited: 5
Current Status and Future Prospects of Lyotropic Liquid Crystals as a Nanocarrier Delivery System for the Treatment of Cancer
Raj Baldha, G. S. Chakraborthy, Sachin Rathod
AAPS PharmSciTech (2025) Vol. 26, Iss. 2
Closed Access
Gene network analysis of oxaliplatin-resistant colorectal cancer to target a crucial gene using chitosan/hyaluronic acid/protamine polyplexes containing CRISPR-Cas9
Shiva Shirani-Bidabadi, Mina Mirian, Jaleh Varshosaz, et al.
Biochimica et Biophysica Acta (BBA) - General Subjects (2023) Vol. 1867, Iss. 8, pp. 130385-130385
Closed Access | Times Cited: 10
Cetuximab chemotherapy resistance: Insight into the homeostatic evolution of head and neck cancer (Review)
Carlos Henrique Diniz, Tiago Henrique, Ana Carolina Buzzo Stefanini, et al.
Oncology Reports (2024) Vol. 51, Iss. 6
Open Access | Times Cited: 3
Mini-organs with big impact: Organoids in liver cancer studies
Muhammad Babar Khawar, YAJUN WANG, ANEEQA MAJEED, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2023) Vol. 31, Iss. 5, pp. 677-688
Open Access | Times Cited: 5
Fabrication and evaluation of a dual-targeting nanoparticle mediated CRISPR/Cas9 delivery to combat drug resistance in breast cancer cells
Nazita Tavazohi, Mina Mirian, Jaleh Varshosaz, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 86, pp. 104628-104628
Closed Access | Times Cited: 4
Long noncoding RNAs as regulators of epithelial mesenchymal transition in breast cancer: A recent review
Nahla E. El‐Ashmawy, Eman G. Khedr, Mariam A. Abo-Saif, et al.
Life Sciences (2023) Vol. 336, pp. 122339-122339
Closed Access | Times Cited: 2
Successes and challenges in modeling heterogeneous BRAFV600E mutated central nervous system neoplasms
Yao Lulu Xing, Dena Panovska, Claudia Petritsch
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 1
Page 1

Scroll to top